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ABSTRACT
The conformational dynamics induced by ligand
binding to the tetracycline-binding aptamer is moni-
tored via stopped-flow fluorescence spectroscopy
and time-correlated single photon counting experi-
ments. The fluorescence of the ligand is sensitive to
changes within the tertiary structure of the aptamer
during and after the binding process. In addition to
the wild-type aptamer, the mutants A9G, A13U and
A50U are examined, where bases important for
regulation are changed to inhibit the aptamer’s
function. Our results suggest a very fast two-step-
mechanism for the binding of the ligand to the
aptamer that can be interpreted as a binding step
followed by a reorganization of the aptamer to ac-
commodate the ligand. Binding to the two direct
contact points A13 and A50 was found to occur in
the first binding step. The exchange of the structur-
ally important base A9 for guanine induces an
enormous deceleration of the overall binding pro-
cess, which is mainly rooted in an enhancement of
the back reaction of the first binding step by several
orders of magnitude. This indicates a significant
loss of tertiary structure of the aptamer in the ab-
sence of the base A9, and underlines the importance
of pre-organization on the overall binding process of
the tetracycline-binding aptamer.
INTRODUCTION
During the last years, the folding dynamics of aptamers
and riboswitches as well as the formation of RNA–ligand
complexes have been examined in various contexts. A
variety of time-resolved spectroscopic techniques (1)
such as NMR (2–5), also in combination with the ultrafast
release of caged ligands (6) and ﬂuorescence stopped-ﬂow
have been applied. The latter has been based both on
ﬂuorescent ligands (7–9) and the ﬂuorescent adenine
derivate 2-aminopurine (7,10–12), the lifetime of which
can also be used to gain information on the RNA con-
formation (13). The monitoring of ﬂuorescent ligands has
mostly led to the observation of one-step binding pro-
cesses (7–9,11), however, when monitoring different
parts of thesame aptamer, varying conformational dynam-
ics were found, leading to a signiﬁcantly more complex
overall picture (11,13). A central, but unresolved issue is
the notion of pre-organization of the RNA before ligand
recognition to accommodate binding. These references
provide discussion of conformational capture (14) and
induced ﬁt mechanisms for a variety of systems (15).
The tetracycline-binding aptamer (Figure 1) identi-
ﬁed by in vitro selection [SELEX; (16)], is an interest-
ing genetic device for application in synthetic biology. It
has been used for conditional control of translation initi-
ation (17–19) and pre-mRNA splicing in yeast (20). In
both cases, the aptamer–ligand complex interferes with
protein functions either by steric hindrance or masking
of binding sites.
The aptamer resembles a complex h-shaped structure
with the ligand-binding site in the centre of the three-
way junction [Figure 1C; (21)]. The core of the aptamer
is formed by an irregular triple helix resulting from both
joining regions J1-2 and J2-3 and nucleotides of loop L3.
A base triplet between A9, A44 and A55 forms the basis of
the triple helix (Figure 1D).
The ligand tetracycline (Figure 1B) binds within this
interface as a magnesium ion chelate with a sub-
nanomolar dissociation constant of 770pM (22).
Thermodynamic analysis and the crystal structure of the
aptamer–ligand complex give insight into a variety of
interactions between the aptamer and its ligand (21,22).
A main contact occurs at the adenine nucleotide A13 from
the joining region J1-2 which forms two hydrogen bonds
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 to the 6b-OH group of tetracycline (Figure 1E). The
b-hydroxyketone moiety of tetracycline is deeply buried
in the RNA with ring CD stacking on A58 of the loop
L3. A58 together with A50 indirectly recognize the ligand
via hydrogen bonds to a coordinating water molecule of
the tetracycline’s counterion (Figure 1E) (21). It is, as of
now, unclear, to which extent the tertiary structure is
already formed in the absence of ligand. However,
genetic, biochemical and biophysical data suggest signiﬁ-
cant pre-organization on the secondary and tertiary struc-
tural level (22–24).
This work now focuses on the binding dynamics of the
tetracycline aptamer and the structural conﬁnement of
tetracycline in the binding pocket. Both properties are
monitored via the tetracycline ﬂuorescence that is strongly
enhanced upon binding to the aptamer (22). Thus, it pro-
vides a sensitive probe to monitor the binding process and
conditions by means of ﬂuorescence spectroscopy (25).
The ﬂuorescence lifetime of the chromophore is used to
report on its general conﬁnement, while the change in
tetracycline quantum efﬁciency is used for a real-time ob-
servation of the binding events.
MATERIAL AND METHODS
Preparation of aptamer RNA
Aptamer RNA was transcribed in vitro from a linearized
pSP64 plasmid (Promega) using T7 polymerase. For
precise aptamer 30-ends, the primary transcripts contained
self-cleaving hammerhead ribozymes (Supplementary
Figure S1). Run-off transcription was performed as pre-
viously described (22). After in vitro transcription and
ethanol precipitation, the RNA products were separated
on an 8% denaturing polyacrylamide gel, detected by
ultraviolet shadowing and gel eluted. After a second etha-
nol precipitation, the RNA was resuspended in H2O and
stored frozen at  20 C.
RNA concentrations were calculated with aptamer
speciﬁc extinction coefﬁcients using the ‘Oligonucleotide
MW and Extinction Coefﬁcient Calculator’ from Ambion
(http://www.ambion.com/techlib/misc/oligo_calculator.
html). The tetracycline concentration was determined mea-
suring the optical density at the absorption maximum in
water (26).
Yeast tRNA (Invitrogen) was used as non-speciﬁc RNA
control. For all ﬂuorescence measurements, RNA and
tetracycline stock solutions were prepared in water and
diluted with a 5-fold concentrated buffer (ﬁnal buffer con-
ditions: 20mM potassium phosphate pH 7.5, 100mM
NaCl and 10mM MgCl2). For the ﬂuorescence lifetime
measurements in the TCSPC setup, samples were prepared
at equal concentrations of RNA and tetracycline at 20mM
in the above mentioned buffer, stopped-ﬂow measure-
ments were carried out at varying concentrations, which
are given at each individual measurement.
Time correlated single photon counting
A detailed description of the combined TCSPC/
Upconversion setup has been described in detail previously
(27). In short, pulses of a Spectra Physics Tsunami-
Spitﬁre-system (Newport Spectra Physics, Irvine,
California) operating at 770nm at a pulse width of 130fs
and pulse energy of 1mJ per pulse were frequency doubled.
The excitation energy at 385nm was tuned to 100nJ.
Fluorescence was separated spatially and with a
FGL435-ﬁlter from the excitation light and then passed
Figure 1. The tetracycline-binding aptamer. (A) Secondary structure and (C) crystal structure (21) of the tetracycline-binding aptamer. Stem regions
P1-P3, the joining regions J1-2 and J2-3 and the loop L3 are colored and marked. Tetracycline is shown as green stick model, magnesium as green
ball. (B) Ball and stick representation of tetracycline. (D) The base triplet between A9, A44 and A55, which forms the basis of the triple helix.
(E) Location of the nucleotides A13 and A50 with respect to tetracycline.
2 Nucleic AcidsResearch, 2011
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 through a Jobin Yvon Gemini 180 double mono-
chromator (HORIBA Jobin-Yvon, Munich, Germany).
Detection was carried out using a cooled single photon
counting detector head PMC 100-4 (Becker & Hickl,
Berlin, Germany). TCSPC data acquisition was managed
by a Becker & Hickl MSA 1000 counting system (Becker
& Hickl, Berlin, Germany). It provides a channel width of
1ns and a maximum number of 1024 channels. A fused
silica cuvette with 1mm optical path length was used and
moved in two dimensions perpendicular to the incident
beam to avoid excessive photobleaching. A total of
25 measurements have been carried out at different wave-
lengths between 460 and 580nm, using 60000 cycles per
transient.
Absorption spectra were taken before and after the
measurement to estimate the photobleaching within the
sample during the measurement. In all experiments
reported here no photobleaching was observed.
Data analysis was carried out using a global ﬁt analysis
routine on the basis of a Levenberg-Marquart algorithm
assuming a Gaussian-shaped cross correlation of 1.2ns.
Stopped-ﬂow spectroscopy
Stopped-ﬂow transients were taken in a Jasco SFM-20
Stopped-ﬂow setup (Jasco, Groß-Umstadt, Germany)
using a cuvette (FC08) with an approximate volume of
20ml and a light path of 0.8mm, which results in a dead
time of 1.6ms. The samples were excited with a UV LED
at 375nm (PUR LED, Hahnheim, Germany). The
channel width was set to 20ms for all measurements.
Fluorescence was collected under an angle of 90 . The
emission light was separated from the excitation by two
ﬁlters with a cut-off wavelength of 435nm (FGL435,
T h o r L a b s ,K a r l s f e l d ,G e r many) and detected by a
Hamamatsu PMT H9656-20 photomultiplier (Hamamatsu
Deutschland, Herrsching, Germany). Both light source
and detector were placed close to the cuvette to minimize
intensity loss due to stray light. A series of measurements
were carried out for the wild-type and all three mutants,
where for two different aptamer concentrations the tetra-
cycline concentration was varied over a wide range (details
are given in each ﬁgure). A control experiment with
non-speciﬁc tRNA is shown in Supplementary Figure S4
to reassure that no unspeciﬁc binding occurs. The data
were averaged over 20 (for the higher RNA concentration
of  7mM) or 40 (for the lower RNA concentration of
 2mM) identical measurements.
Prior to ﬁtting, all transients were corrected for the
ﬂuorescence signal of unbound tetracycline by subtracting
a constant offset from every transient. The transients were
normalized, taking into account an estimate of the system
evolution during the instrumental dead time, a correction
for LED drift and the total concentration of RNA–tetra-
cycline complexes in the sample (details on the normaliza-
tion procedure, see Supplementary Figure S2).
Each set of transients was processed using the Dynaﬁt
software (28,29) (Biokin Ltd., Watertown, USA) to test
different and to derive the appropriate reaction model
and reaction constants (details on the ﬁtting procedure,
see Supplementary Figures S2, S3 and Supplementary
Table S1).
RESULTS
Tetracycline binds to the aptamer in a two-step process
Stopped-ﬂow-measurements allow monitoring dynamic
processes in the time range of milliseconds to seconds.
We used this technique to monitor the formation
of the tetracycline aptamer complex in a time-resolved
manner. The steady-state ﬂuorescence of the tetracycline
was used as a reporter signal similar as for the previous-
ly reported equilibrium binding constant measurements
(22).
The binding dynamics of the tetracycline-binding
aptamer was recorded at room temperature using two
different aptamer concentrations of 1.8 and 6.8mM. The
corresponding tetracycline concentrations were varied be-
tween 6–46mM and 12–101mM, respectively. Figure 2A
shows the measured set of transients. Binding of tetra-
cycline to the aptamer leads to a signiﬁcant increase in
ﬂuorescence. In contrast, no ﬂuorescence increase was
observed for tRNAs as a non-speciﬁc RNA control
(Supplementary Figure S4). The binding dynamics of the
wild-type aptamer is extremely fast and increases with
rising tetracycline concentrations. In the observed concen-
tration range, complete ligand binding is induced well
below 50ms. This is two to three orders of magnitude
faster than it has been observed for the aptamer
domains of several riboswitches such as the FMN, TPP
or the adenine riboswitch (6,8,9,12) and is in accordance
with the remarkably low KD of the tetracycline-binding
aptamer.
The collected data have been ﬁtted using the program
Dynaﬁt. A number of different reaction models were
assumed and their root-mean-square deviations and the
overall reaction constants compared with each other (for
details see Supplementary Figure S3 and Supplementary
Table S1). A comparative analysis of several one-step,
two-step and three-step models showed, that a one-step
model cannot describe the data sufﬁciently, while a
three-step model shows no signiﬁcant improvement over
a two-step model. The ﬁrst step was found to be reversible,
while the additional assumption of a reversible second step
yields negligible back reaction rates. This leads to the con-
clusion, that a two-step mechanism with an irreversible
second step is the most probable reaction path for the
binding of tetracycline to the aptamer. Figure 2B shows
selected transients for both aptamer concentrations and
their respective ﬁts. The resulting reaction constants are
given in Table 1.
The ﬁrst step induces a signiﬁcant ﬂuorescence rise, add-
ing up to slightly <50% of the total ﬂuorescence increase
indicating a signiﬁcant conformational restriction of the
chromophore. The formation rate is 13.1±0.1(mMs)
 1
and the dissociation rate of the intermediate complex is
35±2s
 1. In a second binding step, the ligand is enclosed
into the aptamer-binding pocket with a rate constant of
155±7s
 1.
Nucleic Acids Research, 2011 3
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 Positions with direct contacts to the ligand have only
marginal inﬂuence on the binding process
The analysis of mutants allows conclusions on the partici-
pation of different regions in the binding of the ligand.
The bases A13 and A50 of the aptamer are located
within the two regions J1-2 and L3, respectively, which
are important for ligand binding (Figure 1C and E).
Mutations at both positions (A13U and A50U) have a
dramatic effect on ligand binding with a decrease in KD
by more than two orders of magnitude and render the
aptamer regulatory inactive (22,24). Thereby, two direct
H-bonds between the 6b-OH of tetracycline to the adenine
at position 13 are missing in A13U (21). It has been
assumed before, that binding to A13 occurs early in the
reaction process (22). In the A50U mutant, a contact
involved in correct positioning of the tetracycline
counterion is removed (21). In this mutant the correct
formation of loop L3 and the binding pocket will be
impaired.
Two different RNA concentrations of A50U were
investigated (1.8 and 7.8mM) and the tetracycline concen-
tration was varied from 6–52mM and 12–190mM, respect-
ively. A number of transients corresponding to the
different concentration ratios (see ‘Materials and
Methods’ section) were taken and analysed. For A13U,
1.5 and 10mM aptamer RNA was used with the tetracyc-
line concentrations varying from 11–64mM to 15–155mM,
respectively. Figures 3A and 4A show two different tran-
sients of A50U and A13U, respectively, in comparison
with the wild-type. Inspection of the ﬂuorescence
dynamics directly shows that both mutations slow down
the binding dynamics to a small but signiﬁcant extent.
Analogous to the wild-type, a comparison between
various reaction models was carried out on the basis of
the collected data. Again, a two-step model with an irre-
versible second step was found as the most probable
binding model (ﬁts are shown in Figures 3B and 4B for
selected transients). The ﬁtting yielded reaction con-
stants of k1=7.3±0.1 (mMs)
 1, k 1=13±2s
 1 and
k2=124±8s
 1 for A50U and k1=5.50±0.05
(mMs)
 1, k 1=14±1s
 1 and k2=78±2s
 1 for A13U.
Similar to wild-type, steps 1 and 2 contribute almost
equally to the ﬂuorescence intensity, with the A13U
mutant showing the smallest increase in step 1 with
44.3±0.3% (Table 1).
The reaction constants, especially k2, of A50U differ
only moderately from those obtained in the wild-type
analysis. All three reaction constants are slowed down,
leading to overall decelerated global dynamics. To
analyse the relevance of the differences between the
Figure 2. Binding dynamics of the wild-type aptamer in dependence of both tetracycline and RNA concentrations. The emission light was separated
from the 375nm excitation by two ﬁlters with a cut-off wavelength of 435nm. The shown transients are an average of 40 (1.8mM RNA) or
20 (6.8mM RNA) individual measurements. (A) Selected transients for the binding process over a wide concentration range. (B) Data and ﬁt
using a two-step model for the binding of the ligand to the RNA.
Table 1. Tetracycline lifetime measurements and reaction constants for ligand binding to the tetracycline aptamers assuming
a two-step process with an irreversible second step
t1/ns k1/(mMs)
 1 k  1/s
 1 k2/s
 1 F1/% F2/%
WT 4.37±0.04 13.1±0.1 35±2 155±7 49.7±0.2 50.3±0.1
A50U 3.62±0.02 7.3±0.1 13±2 124±8 48.2±0.3 51.8±0.3
A13U 3.78±0.02 5.50±0.05 14±1 78±2 44.3±0.3 55.7±0.2
A9G 4.06±0.04 60±20 13000±5000 51±2 7±1 93.1±0.1
Fi represent the relative contributions of step i to the total increase of ﬂuorescence and ki describes the corresponding rate
constants.
4 Nucleic AcidsResearch, 2011
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 kinetics of A50U and wild-type, a comparison was made
between different two-step models by ﬁtting the A50U
transients with a set of two-step models with either the
ﬁrst or the second step reaction constants ﬁxed to those
of the wild-type. A quantiﬁcation of the deviation of the
respective ﬁt due to the reduction of the parameter space
allows an estimate of the inﬂuences of A50 on the ﬁrst and
second reaction steps. Table 2 shows the ﬁt results as well
as the RMS and the Akaike value [AIC; (30)], which
gives an estimate on the relevance of a model compared
to a reference. In this case, the reference was the above
described ﬁt of the A50U kinetics with a two-step model.
The AIC is dependent on both the RMS and the number
of degrees of freedom in the system and thus provides an
estimate on the quality of a ﬁt.
It can be seen, that a ﬁt with a ﬁxed second step
provides a signiﬁcantly better match than the ﬁt with a
ﬁxed ﬁrst step. An Akaike value of 13 signiﬁes a small but
non-vanishing probability of  0.2% for the model to
describe the data more accurately than the reference
model. An Akaike value of 880, however, signiﬁes that
there is no support for this model to describe the data.
In conclusion, the base A50 exhibits a signiﬁcant inﬂuence
on the ﬁrst binding step, and a smaller inﬂuence on the
second binding step.
In contrast, the inﬂuence of A13 on both reaction steps
is nearly equally strong. This is supported by the fact that
a discriminative analysis between two-step models with
ﬁxed ﬁrst or second steps yielded very high AIC-values
for both cases (5538 and 1106 for ﬁxed ﬁrst and second
step, respectively). Therefore, in contrast to A50, the base
A13 is highly important for both reaction steps.
Mutation of A9, involved in tertiary structure formation,
yields dramatically altered binding dynamics
Mutation of A9 leads to a rise of the KD by a factor of 210
and renders the tetracycline-binding aptamer regulatory
inactive, too (22,24). The A9G mutant is lacking the
central base of the base triplet formed by A44, A9 and
Figure 3. Binding dynamics of the A50U mutant. The emission light was separated from the 375nm excitation by two ﬁlters with a cut-off
wavelength of 435nm. The transients shown for A50U are an average of 40 (1.8mM RNA) or 20 (7.8mM RNA) individual measurements. (A)
Comparison of the wild-type and A50U dynamics at two different concentration combinations. Transients are normalized to 1 at the ﬂuorescence
maximum. (For details on the normalization procedure, see Supplementary Figure S2). (B) Data and ﬁt using a two-step model for the binding of the
ligand to A50U.
Nucleic Acids Research, 2011 5
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 A55 which is assumed to be a key element of the tertiary
structure of the tetracycline-binding aptamer (Figure 1D).
Its exchange to guanine prevents the formation of three
hydrogen bonds thus the three-way junction can presum-
ably not be formed in contrast to the wild-type. It has been
proposed that A9 is important for the pre-organization of
the aptamer in the unbound state as the mutant is less
pre-structured. This is reﬂected by a higher read-through
in translation assays (24) and a more unfavourable
binding entropy compared to the wild-type (22).
The dynamic implications of the mutation at position 9
(A9G) was examined by measurements at two different
concentrations of RNA (1.8 and 9mM) and tetracycline
(6–52 and 22–228mM), respectively. Figure 5A shows that
the reaction is slowed down dramatically in comparison to
the wild-type in the same concentration range.
An analysis of the reaction constants indicated that the
main reason for this can be found in a drastic increase of
the back reaction rate of the ﬁrst reaction step
(k 1=13 10
3), which is accelerated by three orders of
Figure 4. Binding dynamics of the A13U mutant. The emission light was separated from the 375nm excitation by two ﬁlters with a cut-off
wavelength of 435nm. The transients shown for A13U are an average of 40 (1.5mM RNA) or 20 (10mM RNA) individual measurements.
(A) Comparison of the wild-type and A13U dynamics at two different concentration combinations. Transients are normalized to 1 at the ﬂuorescence
maximum. (For details on the normalization procedure, see Supplementary Figure S2). (B) Data and ﬁt using a two-step model for the binding of the
ligand to A13U.
Table 2. Analysis of the differences in reaction constants between the wild-type and the mutant A50U
k1/(mMs)
 1 k 1/s
 1 k2/s
 1 RMS AIC
WT 13.1±0.1 35±2 155±7 –
A50U 7.3±0.1 13±2 124±8 0.207141 0
Step 1 13.1* 35* 132±2 0.221183 880
Step 2 7.59±0.08 20±1 155* 0.207198 13
Separate ﬁts have been performed, where the ﬁrst or second step was ﬁxed (indicated by Asterisk) to the wild-type constants to
determine the inﬂuence of the missing base A50U on the respective reaction step.
6 Nucleic AcidsResearch, 2011
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 magnitude (Figure 5B and Table 1). This indicates either a
masking of the correct binding site or a large number of
aptamer conformations able to bind the ligand, but unable
to form a correct binding pocket before the ligand dissoci-
ates again. This picture is supported by the relative ﬂuor-
escence rises F1 and F2, which were also determined by
the ﬁtting routine.
It is remarkable, that the ﬁrst binding step only accounts
for  7% of the total ﬂuorescence rise, while in the wild-
type and the A13U and A50G mutants it is responsible for
nearly half of the total signal. The ﬁrst binding step is
therefore only responsible for a small conformational re-
striction of the ligand by the aptamer, pointing to a sig-
niﬁcantly more open conformation of this aptamer with
respect to the previously examined mutants.
Tetracycline is highly restricted in the binding pocket
The excited state lifetime of a chromophore is connected
to its quantum efﬁciency (31,32). Both are often associated
with the degree of mobility that the chromophore exhibits,
provided that the surroundings of the chromophore are
similar in terms of other ﬂuorescence quenching paths.
The ﬂuorescence lifetime of chromophores can be
inﬂuenced by a number of environmental factors, such
as solvent polarity or stacking of the chromophore with
neighbouring aromatic systems.
The ﬂuorescence of tetracycline is dependent on the vi-
brational de-excitation pathways allowed by its conform-
ation and surroundings. As an example, already the
complex formation of the chromophore with a counterion
leads to a signiﬁcantly longer excited state lifetime (33).
Therefore, lifetime measurements using the Time
Correlated Single Photon Counting (TCSPC) technique
have been carried out on the tetracycline aptamer complex
to obtain information about the binding pocket of the
wild-type aptamer and the aptamer mutants A9G, A13U
and A50U. Assuming that the conﬁnement of the chromo-
phore is the major inﬂuence of the aptamer on the tetra-
cycline ﬂuorescence, a comparable rise of the tetracycline
ﬂuorescence for the wild-type and the mutants would be
indicative for a proper formation of a tetracycline restricting
binding pocket. The crystal structure of the aptamer (21)
Figure 5. Binding dynamics of the A9G mutant. The emission light was separated from the 375nm excitation by two ﬁlters with a cut-off wavelength
of 435nm. The transients shown for A9G are an average of 40 (1.8mM RNA) or 20 (9mM RNA) individual measurements. (A) Comparison of the
wild-type and A9G dynamics at two different concentration combinations. Transients are normalized to 1 at the ﬂuorescence maximum. (For details
on the normalization procedure, see Supplementary Figure S2). (B) Data and ﬁt using a two-step model for the binding of the ligand to A9G.
Nucleic Acids Research, 2011 7
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 does not point to strong stacking interactions within the
binding pocket, which could quench the ﬂuorescence sig-
niﬁcantly. Thus, lifetime measurements of the tetracycline
ﬂuorescence reﬂect mainly the conﬁnement and position-
ing of the chromophore in the bound state.
TCSPC measurements for the wild-type aptamer and all
three mutants were performed and transients for all tetra-
cycline aptamer complexes were collected at 470nm
(Figure 6 and Table 1). In accordance to prior studies, a
non-monoexponential photophysical behaviour of the
tetracycline chromophore was observed (33,34). In the
cited studies, complex excited state relaxation processes
such as charge transfer processes occur on the picosecond
timescale which are below the time resolution of our setup.
Our experiment thus only determines the overall lifetime
of the lowest excited state, which can be described by a
mono exponential decay for all aptamers. They show
small but nevertheless signiﬁcant differences due to the
very accurate lifetime determination (see error for t1 in
Table 1). Much more evident, however, is the difference
in lifetime between tetracycline in buffer or with a
non-speciﬁc tRNA control and the analysed tetracycline
aptamer complexes (Figure 6). This indicates that—apart
from subtle variations—the binding pockets of the various
tetracycline aptamer complexes are properly formed.
The tetracycline aptamer complex with the longest
lifetime of tetracycline of 4.37±0.04ns is formed with
the wild-type and demonstrates the tight conﬁnement of
the chromophore within the RNA. Tetracycline bound to
the A9G mutant shows a lifetime of 4.06±0.04ns
whereas 3.78±0.02 and 3.62±0.02ns were recorded
for A13U and A50U, respectively. No photobleaching
and no inﬂuence of the buffer or of non-speciﬁc RNA
on the lifetime of tetracycline were observed.
The differences in ﬂuorescence lifetime of tetracycline
bound to the wild-type aptamer and the mutants are sig-
niﬁcant, but rather small. This conﬁrms the notion derived
from the steady-state ﬂuorescence measurements, that
tetracycline adapts a ﬁxed position in the binding pocket
in all aptamers. The small differences in the ﬂuorescence
lifetimes between wild-type and the mutants can be
attributed to differences in the binding pockets of the
analysed aptamers.
DISCUSSION
While there have been many aptamers selected for a wide
variety of ligands, mostly with excellent binding
properties, only very few of them can be exploited for
the control of gene expression (35). This issue is the subject
of ongoing discussions. A complete picture of regulating
aptamers has to be obtained to understand the structural
and mechanistic requirements for an aptamer functioning
as engineered riboswitch. In addition to genetic, biochem-
ical and structural studies, the conformational dynamics
of aptamers has to be taken into account to shed light on
the binding process. Therefore, in this study the binding
kinetics of the tetracycline binding aptamer have been
examined for the wild-type and three mutants (A9G,
A13U, A50U) which allow conclusions on the binding
mechanism involved.
The tetracycline aptamer shows a very fast binding with
a two-step behaviour of the binding process. A schematic
model of the binding process is depicted in Figure 7. The
ﬁrst binding step is reversible, while the second one does
not show any signiﬁcant back reaction rate. The two steps
can be interpreted as a ﬁrst association of the ligand with a
subsequent structural reorganization of the RNA to ac-
commodate the ligand within the binding pocket. Such a
two-step-process has often been observed upon ligand
binding to proteins and is usually interpreted as a
Figure 7. Schematics of the binding process of tetracycline (TC) to the aptamer as concluded from the stopped-ﬂow measurements.
Figure 6. TCSPC measurements of the ﬂuorescence lifetime of tetra-
cycline (TC) alone, with non-speciﬁc tRNA or bound to the wild-type
and the three mutants A9G, A13U and A50U. Excitation energy at
385nm was tuned to 100nJ, the transients at 470nm are shown. Each
transient is an average of 60000 single sweeps.
8 Nucleic AcidsResearch, 2011
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 binding step with a subsequent conformational change
(36,37).
The presence of signiﬁcant secondary structural elem-
ents even in the absence of tetracycline would support this
mechanism. Indeed structural probing indicated that large
parts of the aptamer are already formed without tetra-
cycline (24). Analytical size exclusion chromatography as
well as native PAGE experiments detected no major con-
formational changes upon tetracycline binding (22). A
preformation of the aptamer is further supported by an
inhibition of gene expression already in the absence of
tetracycline (17–19). EPR measurements also strongly sug-
gest a pre-organization. Distinct label distributions
indicate a ligand independent structure formation (23).
The fact, that the speed of the reaction is signiﬁcantly
higher than for previously reported aptamer dynamics also
supports the suggestion that only small structural changes
occur upon ligand binding.
The two-step mechanism is in contrast to the previously
observed single-step mechanisms reported for the aptamer
domains of several riboswitches (8,9) and points to a
distinct feature of the tetracycline aptamer. Presumably,
in RNAs with more open conformations (such as the ad-
enine riboswitch), a possible ﬁrst step may not be linked to
a signiﬁcant ﬂuorescence change of the ligand chromo-
phore and may therefore not be observed in similar
studies.
The single-stranded regions of the tetracycline-binding
pocket form two halves opposing each other (Figure 1;
J1-2 versus L3). Mutations on both sides (J1-2: A13U
and L3: A50U) show an inﬂuence on the ﬁrst binding
step, indicating that both aptamer halves are important
for the ﬁrst association step. This is also reﬂected by the
fact that the ﬁrst binding step in these mutants corres-
ponds to half of the rise in ﬂuorescence change, like in
the wild-type. The double mutant has a low KD of
 10mM( 22). It is mimicked by the measurement of
A50U with doxycycline since doxycycline lacks the
R6b-OH group and thus the same RNA/ligand contact as
the A13U/tetracycline sample. When both contacts are
missing, no increase in ﬂuorescence is detectable
(Supplementary Figure S5).
The disturbance of the second binding step in A13U is
signiﬁcant as well. The reaction rate is roughly half as
large as in the wild-type. The reason for this can be
either found in a less favourable intermediate position in
A13U or in an active role of A13 during the second
reaction step of the wild-type binding kinetics.
In general we only detect small inﬂuences in the associ-
ation rate in the A13U and A50U mutants. We have to
note that in our experiments we operate well above the KD
of all mutants (at least 10-fold on RNA and 30-fold on
tetracycline level) due to a limited signal to noise ratio of
the free tetracycline. It was shown before that mutants
exhibiting a strong inﬂuence under equilibrium conditions
can display nearly wild-type dynamics when measured
under non-equilibrium conditions (38). That may also be
responsible for the observation that 100% complex for-
mation occurs, with no detectable back reaction of the
second binding step.
Taken together, the absence of one of the direct
contacts between the ligand and the aptamer leads to a
destabilization of the binding pocket and to a moderate
change in the speed of one or both binding steps. The
inﬂuence on the ﬁrst binding step is clearly recognizable,
in both the A13U and A50U mutants.
The most striking inﬂuence on the binding process is
exerted by replacement of the base A9. In the mutant
A9G, the overall binding process is slowed by several
orders of magnitude. The main reason for this can be
found in the huge back reaction rate of the ﬁrst binding
step, which exceeds that of the wild-type by more than two
orders of magnitude. This fact points to the idea, that
there may be different conformations in A9G, which are
more or less able to bind the ligand only temporarily
without proceeding to the formation of a correct binding
pocket before the ligand dissociates again. It is remark-
able, that the ﬁrst binding step only accounts for  7% of
the total ﬂuorescence rise in A9G in contrast to  50% for
wild-type, A13U and A50G. This indicates that in A9G
the ﬁrst binding step is responsible for only a small con-
formational restriction of tetracycline pointing to a signiﬁ-
cantly more open conformation of the A9G mutant. In
this open conformation tetracycline may be able to
interact only with one of the aptamer halves during the
ﬁrst binding step. In the second step tetracycline forms
contacts to the other half leading to the formation of the
binding pocket detectable by the rise in ﬂuorescence. Due
to the more open conformation of the unbound state it is,
however, very unlikely that the ligand meets an aptamer
conformation that allows the formation of a correct
binding pocket already during the ﬁrst binding step; so
that a large number of the temporarily formed complexes
dissociate before correct complete formation can take
place.
The reorganization of the RNA from the intermediate
to the ﬁnal bound state is slowed by a factor of three with
respect to the wild-type. Considering, that tetracycline
meets a more open conformation, this is only a small
effect. The reason for the high speed of this process can
be found in the fact, that only few conformations are
capable of completing this step. These conformations pre-
sumably are very similar to that of the wild-type. Similar
effects have already been observed and discussed for other
aptamers (8,12). If such a suitable conformation is avail-
able, the formation of the ligand RNA complex occurs
with a relatively high rate.
The ﬂuorescence lifetimes indicate that the ﬁnal state of
the binding process and the restriction of tetracycline
within the binding pocket are pretty similar for all analysed
aptamers. The lifetime measurements of the bound state
showed only small variations (tWT>tA9G>tA13U>
tA50U). A9G shows the longest lifetime of the mutants
which allows the conclusion that the shape of the ﬁnal
binding pocket itself is similar to wild-type and mostly
dependent on tetracycline and its direct contacts to the
RNA and less on the pre-organization of the aptamer (22).
If a direct contact between the ligand and the aptamer is
missing, the chromophore is slightly more ﬂexible within
its binding pocket, as can be seen by the shorter ﬂuores-
cence lifetime of tetracycline in the A13U and A50U
Nucleic Acids Research, 2011 9
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 mutants. A50U exhibits the shortest lifetime of all exa-
mined complexes. Mutation of A50 leads to a more fa-
vourable entropy of binding, because tetracycline does not
interact with loop L3 in a similar way to the wild-type,
suggesting a minor loss of degrees of freedom (22).
Previous studies by EPR spectroscopy revealed a
thermodynamic equilibrium of two aptamer conform-
ations in the free form, with one of the conformations
stabilized upon tetracycline binding (23). Both free con-
formations differ in the location of the junction J1-2
relative to stems P1 and P2 and loop L3. We suggest
that displacement of junction J1-2 allows a ﬁrst associ-
ation of tetracycline already contacting J1-2 through
A13 and/or L3 by the A50 base. A second reorganization
step then leads to complete complex formation with J1-2
positioned like in the crystal structure.
The measured association rates, as well as previous
ﬁndings, suggest a high degree of pre-formation of the
tetracycline aptamer in the absence of its ligand,
allowing for an outstanding fast association. This extraor-
dinary fast association may be the explanation for the
regulating activity of the tetracycline aptamer. Fast asso-
ciation is important for natural riboswitches acting on the
level of transcription. These riboswitches are comprised of
an aptamer domain and an expression platform, namely a
transcriptional terminator. Here, ligand binding to the
nascent transcript has to occur within a short time frame
to stabilize the anti-terminator conformation before the
terminator is transcribed (11).
In the case of the tetracycline aptamer we do not have
an additional expression platform since regulation occurs
via steric hindrance of the ribosomal scanning process.
Still it faces a similar problem. There might be only a
small time window in which the pre-formed aptamer is
susceptible for ligand binding before the mRNA is
covered with the translational machinery. Later on,
small ribosomal subunits scanning the 50-UTR may
prevent pre-formation of the aptamer structures which
are necessary for tetracycline binding. On the other side,
the complex has to be rigid enough to withstand oncoming
scanning ribosomes, probably reﬂected by the high restric-
tion of the tetracycline in the binding pocket. Mutations
interfering with one of these two features will therefore
render the aptamer inactive.
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